未登录 分享 收藏
Phase II study of trastuzumab-pkrb plus gedatolisib in patients with HER2-positive metastatic breast cancer who progressed after two or more HER2-directed therapies (vol 11, 107706, 2026) 曲妥珠单抗-pkrb联合吉地洛利希在经两种或以上HER2靶向治疗后进展的HER2阳性转移性乳腺癌患者中的II期研究（卷11，107706，2026） Kim, J. W.; Park, Y. H.; Lee, S.; Ahn, H. K.; Bae, J.; Park, S.; Chae, H.; Kim, J. H.; Lee, K. -H.; Kim, M. H.; Lee, K. E.; Kang, M. J.; Park, I. H.; Chae, Y. S.; Lee, G. W.; Park, K. U.; Lee, E. M.; Park, J. H.; Kim, J. E.; Kim, H. J.; Kim, T. H.; Oh, S. Y.; Ko, S.; Byun, J. H.; Ha, J. Y.; Kwon, J. H.; Lee, S.; Choi, J. Y.; Jung, J. Y.; Park, K. H. 分享 收藏
分享 收藏
SERENA-6 visual patient-reported outcomes and safety: camizestrant for emerging ESR1m advanced breast cancer during first-line endocrine-based therapy SERENA-6视觉患者报告结局与安全性：卡米昔司rant用于新发ESR1m晚期乳腺癌的一线内分泌治疗 Adam Brufsky, MD; Yeon Hee Park, MD; François-Clément Bidard, MD; Erica L Mayer, MD; Wolfgang Janni, MD; Cynthia Ma, MD; Massimo Cristofanilli, MD; Giampaolo Bianchini, MD; Hiroji Iwata, MD; Peter A Fasching, MD; Zbigniew Nowecki, MD; Javier Pascual, MD; Shin-Cheh Chen, MD; Lionel Moreau, MD; Manuel Ruiz-Borrego, MD; Ayelet Shai, MD; Nuri Karadurmus, MD; Kyung Hae Jung, MD; Yuichiro Kikawa, MD; Richard D Baird, MD; Ranya Habash, MD; Rebecca Sugarman, MSc; Steven Fox, MSc; Manuel Selvi Miralles, MD; Cynthia Huang Bartlett, MD; Nicholas Turner, MD; null 分享 收藏
Phase II study of trastuzumab-pkrb plus gedatolisib in patients with HER2-positive metastatic breast cancer who progressed after two or more HER2-directed therapies 曲妥珠单抗-pkrb联合吉地洛昔布在HER2阳性转移性乳腺癌患者中的II期研究，该患者在接受两种或更多HER2靶向治疗后进展 Kim, J. W.; Park, V. H.; Lee, S.; Ahn, H. K.; Bae, J.; Park, S.; Chae, H.; Kim, J. H.; Lee, K. -h.; Kim, M. H.; Lee, K. E.; Kang, M. J.; Park, I. H.; Chae, V. s.; Lee, G. W.; Park, K. U.; Lee, E. M.; Park, J. H.; Kim, J. E.; Kim, H. K.; Kim, T. H.; Oh, S. V.; Ko, S.; Byun, J. H.; Ha, J. V.; Kwon, J. H.; Choi, J. V.; Jung, J. V.; Park, K. H. 分享 收藏
分享 收藏
分享 收藏
Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studies 根据剂量对曲妥珠单抗德鲁替康的安全性特征进行表征：一项跨越DESTINY研究的合并分析 Park, Yeon Hee; Cortes, Javier; Modi, Shanu; Hurvitz, Sara A.; Bianchini, Giampaolo; Iwata, Hiroji; Shitara, Kohei; Siena, Salvatore; Goto, Yasushi; Ku, Geoffrey Y.; Powell, Charles A.; Swain, Sandra M.; Arunachalam, Meena; Janek, Martin; Cheng, Yingkai; Chu, Changan; Verma, Purnima; Kuptsova-Clarkson, Nataliya; Mathias, Elton; Goodman, Erin; Rugo, Hope S. 分享 收藏
Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer 曲妥珠单抗Deruxtecan在早期乳腺癌残留HER2-Positive中的应用 Loibl, Sibylle; Park, Yeon Hee; Shao, Zhiming; Huang, Chiun-Sheng; Barrios, Carlos; Abraham, Jame; Prat, Aleix; Niikura, Naoki; Im, Seock-Ah; Li, Wei; Li, Huiping; Wang, Yongsheng; Yao, Herui; Kim, Sung-Bae; Geng, Cui-zhi; Rodriguez Pantigoso, Wuilbert; Ramirez Godinez, Francisco Javier; Song, Chuangui; Ching Chang, Yuan; Antoniazzi, Augusto; Chen, Shin-Cheh; Li, Zhigao; Nowecki, Zbigniew; Lim, Joline; Mathias, Elton; Sato, Yuta; Lu, Wenjing; Abdel-Monem, Hanan; Untch, Michael; Geyer, Charles E. 分享 收藏
分享 收藏
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer Cortes, Javier; Punie, Kevin; Barrios, Carlos; Hurvitz, Sara A.; Schneeweiss, Andreas; Sohn, Joohyuk; Tokunaga, Eriko; Brufsky, Adam; Park, Yeon Hee; Xu, Binghe; Hegg, Roberto; Oliveira, Mafalda; Fabi, Alessandra; Vaksman, Natalya; Valdez, Theresa; Zhang, Xinrui; Lai, Catherine; Tolaney, Sara M. 分享 收藏
分享 收藏
分享 收藏
Real-world evidence of the efficacy of neoadjuvant pembrolizumab in triple-negative breast cancer: A surgeon's point of view Park, Woong Ki; Nam, Seok Jin; Kim, Seok Won; Yu, Jonghan; Lee, Se Kyung; Ryu, Jai Min; Chae, Byung Joo; Shin, Dong Seung; Ahn, Jin Seok; Park, Yeon Hee; Kim, Ji-Yeon; Shin, Junghoon; Ahn, Hee Kyung; Cho, Eun Yoon; Lee, Hyunwoo; Lee, Jeong Eon 分享 收藏
分享 收藏
分享 收藏
Locoregional recurrence after neoadjuvant versus adjuvant chemotherapy based on tumor subtypes in patients with early-stage breast cancer: A multi-institutional retrospective cohort study Cheun, Jong-Ho; Kwak, Youngji; Kang, Eunhye; Jung, Ji-Jung; Kim, Hong-Kyu; Lee, Han-Byoel; Lee, Kyung-Hun; Moon, Hyeong-Gon; Hwang, Ki-Tae; Park, Yeon Hee; Lee, Jeong Eon; Han, Wonshik 分享 收藏
Results from the randomized KEYNOTE-355 study of pembrolizumab plus chemotherapy for Asian patients with advanced TNBC pembrolizumab联合化疗治疗亚洲晚期TNBC患者的随机355研究结果 Im, Seock-Ah; Cortes, Javier; Cescon, David W.; Yusof, Mastura Md; Iwata, Hiroji; Masuda, Norikazu; Takano, Toshimi; Huang, Chiun-Sheng; Chung, Chi-Feng; Tsugawa, Koichiro; Park, Yeon Hee; Matsumoto, Koji; Inoue, Kenichi; Kwong, Ava; Loi, Sherene; Fu, Wei; Pan, Wilbur; Karantza, Vassiliki; Rugo, Hope S.; Schmid, Peter 分享 收藏
Real-time assessment of relative mitochondrial ATP synthesis response against inhibiting and stimulating substrates (MitoRAISE) Chang, Eun Sol; Song, Kyoung; Song, Ji-Young; Sung, Minjung; Lee, Mi-Sook; Oh, Jung Han; Kim, Ji-Yeon; Park, Yeon Hee; Jung, Kyungsoo; Choi, Yoon-La 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
ESMO Open.png)
.png){kind=icon}
分享.png){kind=icon}
收藏